News | Breast Imaging | August 08, 2016

FDA Breast Imaging Panel Discusses New Ways to Better Assess Mammography Quality

Dense breast tissue’s impact on exam quality will be discussed

dense breast tissue, dense breast imaging, BIRADS, BI-RADS, mammography grading system, comparison of dense breast tissue, Fibroglandular densities

August 8, 2016 — The U.S. Food and Drug Administration’s (FDA) National Mammography Quality Assurance Advisory Committee is considering new measures to improve breast imaging quality and how breast density impacts exams. The panel will discuss these and other items at its next meeting Thursday, Sept. 15, 2016, in Gaithersburg, Md.

The committee provides advice and recommendations to the FDA on agency’s regulatory issues.

The committee will discuss and make recommendations on compliance analysis, focusing on the Mammography Quality Standards Act (MQSA) current compliance trends. The discussion will include trends seen in the analysis, why the trends may be occurring and possible actions that should be sought.     

The panel will also discuss the Inspection Enhancement Project, which is proposes to use the inspection program to enhance breast image quality. FDA is seeking committee input on anticipated facility questions related to the proposal. The approved alternative standard American College of Radiology Full Field Digital Mammography Quality Control Manual contents will be explained and FDA will ask the committee's  advice on facility roll-out strategies.     

The committee will also address issues related to breast density (fibroglandular densities). A presentation will examine the current issues, followed by a committee discussion on how these issues might effect a possible MQSA requirement for reporting breast density.  Future challenges for MQSA include the role of synthesized 2-D images created from 3-D tomosynthesis mammography datasets. The FDA is seeking committee input on this challenge, as well as what future challenges MQSA might encounter.   

Read more about MQSA Mammography Facility Inspector Training. 

For more informtion: www.fda.gov/AdvisoryCommittees/Calendar/ucm515098.htm

 

Related Content

FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Therapixel Appoints Matthieu Leclerc-Chalvet as CEO
News | Artificial Intelligence | July 03, 2019
Artificial intelligence (AI) breast cancer screening specialist Therapixel announced the appointment of Matthieu...
GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

Feature | Breast Imaging | July 03, 2019 | By Greg Freiherr
Productivity and its enabler — efficiency — guided the display of products at the April...
Countless possibilities can impact the future of global healthcare and AI is the first step toward breakthrough that will change the landscape of personalized medicine
Feature | Women's Health | July 03, 2019 | By Samir Parikh
Contrary to what many people believe,...

Image courtesy of GE Healthcare

Feature | Radiology Business | July 03, 2019 | By Jeffrey Hoffmeister, M.D.
Burnout in the medical profession is not uncommon, particularly as clinicians have become more overwhelmed by growing
iCAD ProFound AI

Image courtesy of iCAD

News | Breast Imaging | June 25, 2019
Use of...
Warm Springs Health & Wellness Center Implements Digisonics Solution for OB Ultrasound
News | Ultrasound Women's Health | June 17, 2019
Warm Springs Health & Wellness Center in Warm Springs, Ore., has selected the Digisonics OB PACS (picture archiving...
Fujifilm Announces Nationwide Breast Health Campaign With Mobile Mammography Coach

At the center of the campaign, Fujifilm will be traveling around the U.S. with its "Aspire to Be Fearless" mobile mammography coach to provide educational opportunities for clinicians, raise awareness about the importance of screening and will be providing mammograms to the underserved population in key locations.

News | Mammography | June 14, 2019
Fujifilm Medical Systems U.S.A. Inc. announced a nationwide awareness campaign titled ‘Aspire to Be Fearless’ focused...